Menu
Back to User profile » Prof. Dr. Subhankar Chowdhury
Papers published by Prof. Dr. Subhankar Chowdhury:
TRC150094, a Novel Mitochondrial Modulator, Reduces Cardio-Metabolic Risk as an Add-On Treatment: a Phase-2, 24-Week, Multi-Center, Randomized, Double-Blind, Clinical Trial
Joshi D, GJ P, Ghosh S, Mohanan A, Joshi S, Mohan V, Chowdhury S, Dutt C, Tandon N
Diabetes, Metabolic Syndrome and Obesity 2022, 15:615-631
Published Date: 25 February 2022
Risk Factors Analysis and Management of Cardiometabolic-Based Chronic Disease in Low- and Middle-Income Countries
Dutt C, Nunes Salles JE, Joshi S, Nair T, Chowdhury S, Mithal A, Mohan V, Kasliwal R, Sharma S, Tijssen J, Tandon N
Diabetes, Metabolic Syndrome and Obesity 2022, 15:451-465
Published Date: 16 February 2022
Decreased Levels of miR-126 and miR-132 in Plasma and Vitreous Humor of Non-Proliferative Diabetic Retinopathy Among Subjects with Type-2 Diabetes Mellitus
Pramanik S, Saha C, Chowdhury S, Bose C, Bhattacharyya NP, Mondal LK
Diabetes, Metabolic Syndrome and Obesity 2022, 15:345-358
Published Date: 4 February 2022
Efficacy and Cost-Effectiveness of Anti-VEGF for Treating Diabetic Retinopathy in the Indian Population
Pramanik S, Mondal LK, Paine SK, Jain S, Chowdhury S, Ganguly U, Ghosh S, Bose C, Bhattacharjee K, Bhaduri G
Clinical Ophthalmology 2021, 15:3341-3350
Published Date: 10 August 2021
Remogliflozin Etabonate in the Treatment of Type 2 Diabetes: Design, Development, and Place in Therapy
Mohan V, Mithal A, Joshi SR, Aravind SR, Chowdhury S
Drug Design, Development and Therapy 2020, 14:2487-2501
Published Date: 24 June 2020
Testosterone levels and type 2 diabetes in men: current knowledge and clinical implications
Beatrice AM, Dutta D, Kumar M, Shivaprasad KS, Sinha A, Ray S, Chowdhury S
Diabetes, Metabolic Syndrome and Obesity 2014, 7:481-486
Published Date: 20 October 2014